Mascali A, Franzese O, Nisticò S, Campia U, Lauro D, Cardillo C, Di Daniele N, Tesauro M
Division of Hypertension and Nephrology, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy.
Department of Health Sciences, University of Catanzaro "Magna Graecia", Catanzaro, Italy
Int J Immunopathol Pharmacol. 2016 Sep;29(3):354-63. doi: 10.1177/0394632016643550. Epub 2016 Apr 4.
In industrialized countries, overweight and obesity account for approximately 13.8% and 24.9% of the kidney disease observed in men and women, respectively. Moreover, obesity-associated glomerulopathy is now considered as "an emerging epidemic." Kidney function can be negatively impacted by obesity through several mechanisms, either direct or indirect. While it is well established that obesity represents the leading risk factor for type 2 diabetes and hypertension, awareness that obesity is associated with direct kidney damage independently of hypertension and diabetes is still not widespread. In this paper we will discuss the emerging role of adipose tissue, particularly in the visceral depot, in obesity-induced chronic kidney damage.
在工业化国家,超重和肥胖分别占男性和女性所观察到的肾脏疾病的约13.8%和24.9%。此外,肥胖相关性肾小球病现在被视为“一种新出现的流行病”。肥胖可通过多种直接或间接机制对肾功能产生负面影响。虽然肥胖是2型糖尿病和高血压的主要危险因素这一点已得到充分证实,但肥胖与独立于高血压和糖尿病的直接肾脏损害相关这一认识仍未广泛普及。在本文中,我们将讨论脂肪组织,特别是内脏脂肪库,在肥胖诱导的慢性肾脏损害中所起的新作用。